NCT01428544View on ClinicalTrials.gov

Special Drug Use Investigation (Retrospective) for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment (Over 100kg)

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions

Ataxia

Interventions

DRUG

Fondaparinux sodium

For patients whose body weight is 100 kg or more, fondaparinux is injected 10 mg subcutaneously once daily for treatment of acute pulmonary thromboembolism or acute deep venous thrombosis.